Opening Bell: Futures, Euro Stocks Bounce Ahead Of Fed; Oil Selloff Eases

 | Dec 19, 2018 05:30AM ET

  • US futures, European shares rebound after Asian weakness
  • Oil selloff eases
  • US stock rebound fails as bears push back bulls
  • VIX hits highest close since February
  • h2 Key Events/h2

    Hopes that a dovish Fed would infuse confidence in growth boosted futures on the S&P 500, Dow and NASDAQ 100 as well as European shares, which edged higher this morning, after a mixed Asian session. The oil selloff, which had sent shockwaves across global markets, also eased.

    The STOXX Europe 600 climbed 0.28% at the open, with banks and pharmaceutical companies leading the gains, after a three-day rout sent prices to a near two-year low and shaved 12.06 percent of value off the pan-European benchmark. Bulls temporarily found resistance as bears increased supply, paring gains to 0.15 percent, but the index then resumed its climb to about 0.46 percent in the late European morning.

    The pharmaceutical sector was boosted by a 5.7% jump in GlaxoSmithKline (LON:GSK), after the British multinational drug maker announced a joint venture with Pfizer's (NYSE:PFE) consumer health division as well as plans to split into two businesses: one dedicated to prescription drugs and vaccines, the other arm focused on over-the-counter products.

    During the earlier Asian session, most regional stocks ended lower, after disappointing Japanese trade data added to traders' defensiveness ahead of the Federal Reserve's interest rate decision. Falling energy shares, fueled by oil price jitters also contributed to the selling. Japan’s Nikkei slipped 0.60 percent lower. China’s Shanghai Composite tumbled 1.05%, weighed down by a rout in healthcare stocks due to concerns of a new drug procurement policy. Also, Softbank's (T:9984) telecom unit slid 15 percent below the price of its IPO—the world's second largest after Alibaba's (NYSE:BABA)foray into the public market—an underwhelming debut.

    h2 Global Financial Affairs/h2